Imidil Cream contains Clotrimazole 1% w/w, an antifungal agent belonging to the imidazole class, effective in the treatment of superficial fungal infections. Clotrimazole acts by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. Imidil Cream is indicated for the topical management of dermatophytosis, candidiasis, and pityriasis versicolor affecting the skin. It is suitable for use on affected areas such as the feet, body, and groin. The cream should be applied in a thin layer to the affected area and surrounding skin twice daily, typically for a duration of 2 to 4 weeks, depending on the severity and clinical response. Patients are advised to maintain good hygiene and avoid occlusive dressings unless directed by a healthcare professional. Imidil Cream is generally well tolerated; however, mild local adverse effects such as burning, itching, or irritation may occur. It is contraindicated in individuals with known hypersensitivity to Clotrimazole or any excipients in the formulation. Use during pregnancy and lactation should be under medical supervision. Consultation with a healthcare provider is recommended if symptoms persist or worsen after treatment.